OSU/UH receive $7.5M grant to study slow progression of myopia in kids

NewsGuard 100/100 Score

The University of Houston (UH) is part of a National Institutes of Health (NIH) study to determine whether commercially available, soft bifocal contact lenses slow the progression of nearsightedness in children.

Investigators at UH and The Ohio State University (OSU) Colleges of Optometry were awarded grants from the NIH's National Eye Institute, worth approximately $7.5 million over five years. The Bifocal Lenses In Nearsighted Kids (BLINK) Study is a multicenter randomized clinical trial that will follow nearly 300 children over the course of three years. Dr. David A. Berntsen, an assistant professor in the UH College of Optometry, is the principal investigator for the UH clinical site of this collaborative effort.

Children 7 to 11 years old will be enrolled and randomly assigned to wear soft contact lenses with no reading power, soft contact lenses with medium reading power or soft contact lenses with high reading power. The investigators will measure the length of the eye and the amount of nearsightedness to determine whether light focused by the reading power of the soft bifocal contact lenses in front of the retina will result in slower eye growth and, thus, slower progression of nearsightedness.

"This study will determine whether soft bifocal contact lenses can be used to slow how quickly a child's nearsightedness increases," Berntsen said. "If we find that soft bifocal contact lenses are effective, then the information we learn from this study will aid in optimizing future lens designs to slow eye growth and the progression of nearsightedness in children."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New model predicts kidney injury risk in cancer patients on cisplatin